Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment
Errataetall: |
ErratumIn: Blood Adv. 2024 Apr 23;8(8):1991. - PMID 38619856 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
Blood advances - 7(2023), 24 vom: 26. Dez., Seite 7581-7584 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jian, Yuan [VerfasserIn] |
---|
Links: |
---|
Themen: |
4Z8R6ORS6L |
---|
Anmerkungen: |
Date Completed 16.12.2023 Date Revised 19.04.2024 published: Print ErratumIn: Blood Adv. 2024 Apr 23;8(8):1991. - PMID 38619856 Citation Status MEDLINE |
---|
doi: |
10.1182/bloodadvances.2023011428 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364142782 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364142782 | ||
003 | DE-627 | ||
005 | 20240419232126.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1182/bloodadvances.2023011428 |2 doi | |
028 | 5 | 2 | |a pubmed24n1380.xml |
035 | |a (DE-627)NLM364142782 | ||
035 | |a (NLM)37922425 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jian, Yuan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.12.2023 | ||
500 | |a Date Revised 19.04.2024 | ||
500 | |a published: Print | ||
500 | |a ErratumIn: Blood Adv. 2024 Apr 23;8(8):1991. - PMID 38619856 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a pomalidomide |2 NLM | |
650 | 7 | |a D2UX06XLB5 |2 NLM | |
650 | 7 | |a Bortezomib |2 NLM | |
650 | 7 | |a 69G8BD63PP |2 NLM | |
650 | 7 | |a Thalidomide |2 NLM | |
650 | 7 | |a 4Z8R6ORS6L |2 NLM | |
650 | 7 | |a Dexamethasone |2 NLM | |
650 | 7 | |a 7S5I7G3JQL |2 NLM | |
700 | 1 | |a Chang, Long |e verfasserin |4 aut | |
700 | 1 | |a Shi, Ming-Xia |e verfasserin |4 aut | |
700 | 1 | |a Sun, Ying |e verfasserin |4 aut | |
700 | 1 | |a Chu, Xiao-Xia |e verfasserin |4 aut | |
700 | 1 | |a Xue, Hua |e verfasserin |4 aut | |
700 | 1 | |a Huang, Wen-Rong |e verfasserin |4 aut | |
700 | 1 | |a Shen, Xu-Liang |e verfasserin |4 aut | |
700 | 1 | |a Ma, Jie |e verfasserin |4 aut | |
700 | 1 | |a Jia, Guo-Rong |e verfasserin |4 aut | |
700 | 1 | |a Feng, Ya-Qing |e verfasserin |4 aut | |
700 | 1 | |a Xi, Zhen-Fang |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Yan-Hong |e verfasserin |4 aut | |
700 | 1 | |a Ma, Yan-Ping |e verfasserin |4 aut | |
700 | 1 | |a Xiao, Jing |e verfasserin |4 aut | |
700 | 1 | |a Ma, Guang-Yu |e verfasserin |4 aut | |
700 | 1 | |a Wang, Qing-Ming |e verfasserin |4 aut | |
700 | 1 | |a Bao, Li |e verfasserin |4 aut | |
700 | 1 | |a Dong, Yu-Jun |e verfasserin |4 aut | |
700 | 1 | |a Zhou, He-Bing |e verfasserin |4 aut | |
700 | 1 | |a Sun, Chun-Yan |e verfasserin |4 aut | |
700 | 1 | |a Su, Guo-Hong |e verfasserin |4 aut | |
700 | 1 | |a Yan, Yan |e verfasserin |4 aut | |
700 | 1 | |a Qimuge, Sai-Yin |e verfasserin |4 aut | |
700 | 1 | |a Su, Li-Ping |e verfasserin |4 aut | |
700 | 1 | |a Sun, Jing-Nan |e verfasserin |4 aut | |
700 | 1 | |a Tian, Wei-Wei |e verfasserin |4 aut | |
700 | 1 | |a Sun, Xiu-Li |e verfasserin |4 aut | |
700 | 1 | |a Ing, Hong-Mei |e verfasserin |4 aut | |
700 | 1 | |a Gao, Da |e verfasserin |4 aut | |
700 | 1 | |a Chen, Wen-Ming |e verfasserin |4 aut | |
700 | 1 | |a Li, Jian |e verfasserin |4 aut | |
700 | 1 | |a Gao, Wen |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Blood advances |d 2016 |g 7(2023), 24 vom: 26. Dez., Seite 7581-7584 |w (DE-627)NLM268683263 |x 2473-9537 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2023 |g number:24 |g day:26 |g month:12 |g pages:7581-7584 |
856 | 4 | 0 | |u http://dx.doi.org/10.1182/bloodadvances.2023011428 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2023 |e 24 |b 26 |c 12 |h 7581-7584 |